GSK Plc (GSK)
50.75
-0.46
(-0.90%)
USD |
NYSE |
Oct 23, 16:00
50.74
0.00 (0.00%)
After-Hours: 20:00
GSK Market Cap : 102.65B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 102.65B |
| October 22, 2026 | 103.58B |
| October 21, 2026 | 101.18B |
| October 20, 2026 | 102.41B |
| October 19, 2026 | 100.04B |
| October 16, 2026 | 100.14B |
| October 15, 2026 | 99.15B |
| October 14, 2026 | 96.83B |
| October 13, 2026 | 93.59B |
| October 12, 2026 | 94.90B |
| October 09, 2026 | 94.06B |
| October 08, 2026 | 94.14B |
| October 07, 2026 | 95.11B |
| October 06, 2026 | 94.26B |
| October 05, 2026 | 94.16B |
| October 02, 2026 | 95.13B |
| October 01, 2026 | 95.43B |
| September 30, 2026 | 97.43B |
| September 29, 2026 | 99.82B |
| September 28, 2026 | 100.53B |
| September 25, 2026 | 99.60B |
| September 24, 2026 | 100.43B |
| September 23, 2026 | 100.55B |
| September 22, 2026 | 102.59B |
| September 21, 2026 | 103.32B |
| Date | Value |
|---|---|
| September 18, 2026 | 101.58B |
| September 17, 2026 | 103.28B |
| September 16, 2026 | 101.72B |
| September 15, 2026 | 101.16B |
| September 14, 2026 | 101.24B |
| September 11, 2026 | 97.35B |
| September 10, 2026 | 97.33B |
| September 09, 2026 | 98.36B |
| September 08, 2026 | 98.18B |
| September 04, 2026 | 100.91B |
| September 03, 2026 | 102.89B |
| September 02, 2026 | 102.02B |
| September 01, 2026 | 102.47B |
| August 31, 2026 | 101.64B |
| August 28, 2026 | 102.79B |
| August 27, 2026 | 101.68B |
| August 26, 2026 | 104.03B |
| August 25, 2026 | 105.32B |
| August 24, 2026 | 104.74B |
| August 21, 2026 | 106.01B |
| August 20, 2026 | 105.10B |
| August 19, 2026 | 106.96B |
| August 18, 2026 | 103.46B |
| August 17, 2026 | 101.70B |
| August 14, 2026 | 100.16B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 531.90B |
| Johnson & Johnson | 635.02B |
| Eli Lilly & Co. | 1.199T |
| Merck & Co., Inc. | 358.62B |
| Novo Nordisk A/S | 130.66B |
Market Cap Related Metrics
| PE Ratio | 15.99 |
| PS Ratio | 2.324 |
| PEG Ratio | 0.3335 |
| Price to Book Value | 4.383 |
| Price to Free Cash Flow | 15.64 |
| Price | 50.75 |
| Earnings Yield | 6.25% |
| PEGY Ratio | 0.3101 |
| Operating PE Ratio | 9.297 |
| Normalized PE Ratio | 11.00 |